FDA Issues Recall Alert for Hypoallergenic Infant Formula

January 2, 2024 by Dan McCue
FDA Issues Recall Alert for Hypoallergenic Infant Formula

WASHINGTON — A popular hypoallergenic infant formula has been voluntarily recalled by its manufacturer due to possible Cronobacter sakazakii contamination.

The formula, Nutramigen Hypoallergenic Infant Formula Powder, is manufactured by Reckitt/Mead Johnson Nutrition.

According to an alert issued by the U.S. Food and Drug Administration on Sunday, the agency learned of the possible contamination of the product, which is used by infants with allergies to cow’s milk, from the Israeli Ministry of Health on Dec. 14.

The ministry told U.S. regulators that a contaminated sample was discovered during routine sampling of imported products at the Israeli border. It identified the sampled formula as having been produced at Mead Johnson Nutrition’s Zeeland, Michigan, facility.

The FDA says the notice led to a full scale investigation that included genome sequencing on the sample obtained from the infant formula to confirm the initial findings of Cronobacter species and to determine whether the isolate was Cronobacter sakazakii. 

Cronobacter sakazakii is a pathogen found naturally in the environment that can enter manufacturing facilities and home environments on hands, shoes and other contaminated surfaces. 

While infant formula firms are required to test a representative sample of their product for both Cronobacter and Salmonella species, this verification step does not guarantee the product is free of Cronobacter. 

Cronobacter contamination can occur at very low levels and is not evenly distributed throughout the product, making it difficult to detect. Powdered infant formula is not a sterile product and public health agencies, including the FDA, routinely encourage caregivers to take steps to prepare powdered infant formula as safely as possible. 

The FDA said Sunday that no illnesses have been reported in connection with the recall, and it is likely that most of the formula distributed in the United States has already been consumed.

Consumers who have Nutramigen Hypoallergenic Infant Formula Powder with the batch codes below are advised to stop using it and throw it away or contact Reckitt/Mead Johnson Nutrition for a refund:

  • ZL3FHG (12.6 oz cans).
  • ZL3FMH (12.6 oz cans).
  • ZL3FPE (12.6 oz cans).
  • ZL3FQD (12.6 oz cans).
  • ZL3FRW (19.8 oz cans).
  • ZL3FXJ (12.6 oz cans).

The products have a UPC Code of 300871239418 or 300871239456 and “Use By Date” of Jan. 1, 2025.

The FDA said though Nutramigen is a specialty infant formula, there are substitute infant formulas available. 

The agency further advises that if the infant formula a child uses is unavailable, parents and caregivers should work with their child’s health care provider to find a suitable substitute.

The FDA does not expect that this recall will have a major impact on the U.S. supply and availability of powdered infant formulas.

While the FDA’s inspection is ongoing, all testing conducted to date by the FDA and Reckitt/Mead Johnson Nutrition has been negative for Cronobacter.

The company, meanwhile, has initiated a voluntary recall of 675,030 cans of Nutramigen Powdered Infant Formula distributed to the United States.

Dan can be reached at [email protected] and @DanMcCue

A+
a-
  • baby formula recall
  • FDA
  • Nutramigen Hypoallergenic Infant Formula powder
  • In The News

    Health

    Voting

    Health

    May 1, 2024
    by Dan McCue
    Bipartisan Vote Spells End to Arizona’s Archaic Abortion Law

    PHOENIX — Arizona lawmakers voted to repeal the state’s controversial, Civil War-era ban on abortion on Wednesday with two Republicans... Read More

    PHOENIX — Arizona lawmakers voted to repeal the state’s controversial, Civil War-era ban on abortion on Wednesday with two Republicans joining with Democrats to ensure the measure passed. The vote in the Republican-controlled Arizona state Senate was 16-14, with every Democrat in the chamber and Republicans... Read More

    By Tweaking the IRA, This Legislation Could Save Lives

    The impact of the Inflation Reduction Act on the price of medicine is starting to play out. Measures to cap... Read More

    The impact of the Inflation Reduction Act on the price of medicine is starting to play out. Measures to cap the price of insulin at $35 a month for Medicare enrollees took effect on Jan. 1. In 2025, the IRA will cap annual out-of-pocket prescription drug... Read More

    May 1, 2024
    by TWN Staff
    CDC Issues Warning of E. coli Outbreak Tied to Walnuts

    WASHINGTON — The Centers for Disease Control and Prevention on Tuesday issued a warning to consumers of a risk of... Read More

    WASHINGTON — The Centers for Disease Control and Prevention on Tuesday issued a warning to consumers of a risk of contracting E. coli from Gibson Farms organic walnuts sold in bulk at natural food stores. Most of the cases have occurred in Washington and California. Gibson... Read More

    Some North Carolina Abortion Pill Restrictions Are Unlawful, Federal Judge Says

    RALEIGH, N.C. (AP) — Some of North Carolina government's restrictions on dispensing abortion pills, such as requiring that doctors to... Read More

    RALEIGH, N.C. (AP) — Some of North Carolina government's restrictions on dispensing abortion pills, such as requiring that doctors to prescribe and provide the drug to the patient in person, are unlawful because they frustrate the goal of Congress to use federal regulators to ensure the... Read More

    May 1, 2024
    by Dan McCue
    Feds Extend Deadline for Comment on Corporate Greed in Health Care

    WASHINGTON — Officials overseeing a recently launched cross-government inquiry on the impact of corporate greed on the nation’s health care... Read More

    WASHINGTON — Officials overseeing a recently launched cross-government inquiry on the impact of corporate greed on the nation’s health care system are already extending the deadline for public comment. The comment period was originally set to end on May 6. It has now been extended to... Read More

    May 1, 2024
    by Dan McCue
    Clinical Trial Links Frequent Anger to Increased Risk of Heart Disease

    WASHINGTON — Recurring bouts of anger may increase a person’s risk of developing heart disease, according to a study published... Read More

    WASHINGTON — Recurring bouts of anger may increase a person’s risk of developing heart disease, according to a study published Wednesday in the Journal of the American Heart Association. The study, which was funded by the National Heart, Lung, and Blood Institute, is the first to... Read More

    News From The Well
    scroll top